Day: October 4, 2024

Novaturas Group, the leader in the Baltic tourism market, announces that Darius Undzėnas will take up the position of the company’s Chief Financial Officer (CFO) from October 7. With many years of comprehensive experience in financial management, Mr Undzėnas joins the Group’s top management team in Lithuania, Latvia and Estonia.  “We are confident that Darius’s diverse experience in finance and his management skills gained in international companies will contribute to the goal of strengthening the position of Novaturas in the tourism market. At the same time, we set a strategic goal for the new CFO – to strengthen the company’s financial position, which is important both for ensuring the long-term trust of our customers and partners and for creating long-term value for the company’s shareholders,” said Kristijonas Kaikaris, Chief Executive...

VALNEVA Declaration of shares and voting rights September 30, 2024__________________________________________________________________________________________ Company name: VALNEVARegistered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France)Regulated market of Euronext Paris – Compartment B Declaration date: October 4, 2024Number of shares composing the share capital of Valneva Total number of voting rights including suspended voting rights* Description of the change Date on which this change was recognized Total number of voting rights excluding suspended voting rights**    162,276,901   ordinary shares with a par value of €0.15 each 178,144,731 Transfer into bearer form of 750,000 shares with double voting rights   Capital increase without preferential subscription rights (23,000,000 new ordinary shares issued)   Double...

(4 October 2024 – Oslo, Norway) Reference is made to the stock exchange release by Hexagon Purus ASA (“Hexagon Purus” or the “Company”) on 14 August 2023, where Hexagon Purus and Daimler Truck North America (“DTNA”) signed a long-term agreement for complete vehicle integration of battery electric vocational vehicles. The parties have today mutually agreed to terminate the 2024-2027 supply agreement, and DTNA will reimburse Hexagon Purus for certain costs that the Company has undertaken related to this agreement. The decision unlocks capacity to address other near-term opportunities for strategically attractive battery electric commercial vehicle programs with higher volume and margin potential. It also enables the Company to enhance its focus on the operational execution and scale-up of its long-term agreement for the supply of battery...

   Milan, 4th October 2024 – Recordati today announces an agreement with Sanofi to acquire the global rights to Enjaymo® (sutimlimab), a biologic which is the only approved targeted product for the treatment of cold agglutinin disease (CAD), a rare B-cell lymphoproliferative disorder. Enjaymo® (sutimlimab) is a humanized monoclonal antibody indicated for the treatment of hemolysis in adults with CAD. In 2022, it was granted approval by the U.S. Food and Drug Administration (FDA), the European Commission (EC) and the Japanese Ministry of Health, Labor and Welfare. Administered as chronic IV treatment, Enjaymo® addresses a serious unmet medical need in patients with CAD. Financial highlightsEnjaymo® generated approximately € 100 million in revenue over the last 12 months as of August 2024 and is expected to generate revenue in excess...

On 3 June 2024, Jyske Bank initiated a share repurchase programme that was to be concluded on 31 January 2025 at the latest. In this period, Jyske Bank would acquire shares with a value of up to DKK 1.5 billion, cf. Corporate Announcement No. 12/2024 of 7 May 2024. The share repurchase programme was initiated and structured in compliance with the EU Commission Regulation No. 596/2014 of 16 April 2014, the so-called “Market Abuse Regulation”. Following the transactions stated below, own shares worth DKK 1.5 billion have been repurchased and the programme has been concluded:  Number of shares Average purchase price (DKK) Transaction value (DKK)Accumulated, previous announcement 2,717,007 542.94 1,475,177,47930 September 2024 60 523.26 31,3961 October 2024 20,291 516.35 10,477,1622 October...

Preclinical proof-of-concept data supports CD3 Switch-DARPin platform for T cell engagers with enhanced function in solid tumors Biomarker data on completed phase 1 study of MP0317 (FAP x CD40) shows intended and marked tumor microenvironment modulation ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Oct. 04, 2024 (GLOBE NEWSWIRE) — Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, today announced that the Company will introduce proof-of-concept data for its new CD3 Switch-DARPin designed to overcome current T cell engager challenges in solid tumors, as well as present additional analyses from its Phase 1 study of MP0317 in patients with advanced solid tumors, at the 2024 Annual Meeting of the Society for Immunotherapy...

Alstom Note – Q2 and H1 2024/25 Preview 4 October 2024 – Alstom presents below a preview to its Q2 and H1 2024/25 results. Q2 2024/25 orders The table below summarizes the large orders (more than €200m) published and booked during the quarter.Orders   Value(in € million) Description Link to press releaseProxima ~850 France – 12 very High speed trains with 15Y maintenance Link to the PR  S-Bahn Köln ~3,600 Germany – Frame agreement of 90 trains and 34 years maintenance for ~4bn, o/w ~3.6bn to be booked in Q2, and the rest at a later stage (options) Link to the PR  Perth – Signalling ~650 Western Australia – High capacity signalling project Link to the PR  Total large orders ~5,100    Deals announced previously, but to be booked at a later stageHaifa-Nazareth Systems contract for ~€700m, expected booking in...

Oslo, Norway (4 October 2024) – TGS, a leading global provider of energy data and intelligence will release its Q3 2024 results at approximately 07:00 a.m. CEST on 24 October 2024. CEO Kristian Johansen and CFO Sven Børre Larsen will present the results at 09:00 a.m. CEST at House of Oslo, Ruseløkkveien 34 in Oslo, Norway. The presentation is open to the public and will be webcasted live. Access and registration for webcast attendees are available by copying and pasting the link below into your browser, or use the link on the front page of www.tgs.com: https://channel.royalcast.com/landingpage/hegnarmedia/20241024_5/ The Q3 2024 earnings release and presentation will be available on www.newsweb.no and www.tgs.com. For more information, visit TGS.com (http://www.tgs.com) or contact: Bård Stenberg, VP IR & Communication Mobile:...

Arcadis starts buyback program to repurchase up to 810,000 shares to cover employee incentive plan obligations Amsterdam, October 4, 2024 – Arcadis (EURONEXT: ARCAD), the leading data driven global Design & Consultancy organization for natural and built assets, today announced the start of a share buyback program to repurchase up to 810,000 shares to cover existing and expected future obligations under Arcadis’ employee incentive plans maturing in the next 3 – 4 years. This is in line with Arcadis’ commitment to avoid shareholder dilution from share-based remunerations. The repurchase of shares will commence on October 4, 2024, and is expected to be completed no later than February 4, 2025. The share buyback program will be executed within the parameters of the exemption for buyback programs provided by Article 5 of Regulation...

Hepsor, together with its partner Elysium Investments, has acquired a development project consisting of 17 properties in Toronto in  Brownville Avenue. The development area is planned to feature a high-rise building with rental apartments, which will help alleviate Toronto’s growing housing shortage. In the first phase of the project, the zoning of the area will be changed, and planning activities will be carried out to allow for the future construction of a residential rental building. The first phase is expected to last 24-30 months. The total investment value of the property and the first phase of the project is approximately 24 million euros (about 34 million CAD), of which Brownville Limited Partnership, established for the project’s development, in which Hepsor has a 50% ownership, will invest approximately 5 million...